European Crohn´s and Colitis Organisation - ECCO - P405 Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease – preliminary results from
Teams - ECCO Careers
HR Community | Two Ten
Mindy Moore - Sr Human Resources Business Partner at ECCO Safety Group | The Org